These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 27262364

  • 21. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury.
    Xu X, Yin D, Ren H, Gao W, Li F, Sun D, Wu Y, Zhou S, Lyu L, Yang M, Xiong J, Han L, Jiang R, Zhang J.
    Neurobiol Dis; 2018 Sep; 117():15-27. PubMed ID: 29859317
    [Abstract] [Full Text] [Related]

  • 22. The NLRP3 inflammasome modulates glycolysis by increasing PFKFB3 in an IL-1β-dependent manner in macrophages.
    Finucane OM, Sugrue J, Rubio-Araiz A, Guillot-Sestier MV, Lynch MA.
    Sci Rep; 2019 Mar 11; 9(1):4034. PubMed ID: 30858427
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The NLRP3 inflammasome mediates DSS-induced intestinal inflammation in Nod2 knockout mice.
    Umiker B, Lee HH, Cope J, Ajami NJ, Laine JP, Fregeau C, Ferguson H, Alves SE, Sciammetta N, Kleinschek M, Salmon M.
    Innate Immun; 2019 Feb 11; 25(2):132-143. PubMed ID: 30774010
    [Abstract] [Full Text] [Related]

  • 25. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
    Solini A, Menini S, Rossi C, Ricci C, Santini E, Blasetti Fantauzzi C, Iacobini C, Pugliese G.
    J Pathol; 2013 Nov 11; 231(3):342-53. PubMed ID: 23843215
    [Abstract] [Full Text] [Related]

  • 26. Inhibiting the NLRP3 inflammasome with MCC950 ameliorates retinal neovascularization and leakage by reversing the IL-1β/IL-18 activation pattern in an oxygen-induced ischemic retinopathy mouse model.
    Sui A, Chen X, Shen J, Demetriades AM, Yao Y, Yao Y, Zhu Y, Shen X, Xie B.
    Cell Death Dis; 2020 Oct 22; 11(10):901. PubMed ID: 33093455
    [Abstract] [Full Text] [Related]

  • 27. α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β1-42-stimulated murine astrocytes.
    Ebrahimi T, Rust M, Kaiser SN, Slowik A, Beyer C, Koczulla AR, Schulz JB, Habib P, Bach JP.
    J Neuroinflammation; 2018 Sep 27; 15(1):282. PubMed ID: 30261895
    [Abstract] [Full Text] [Related]

  • 28. Fluorofenidone attenuates interleukin-1β production by interacting with NLRP3 inflammasome in unilateral ureteral obstruction.
    Zheng L, Zhang J, Yuan X, Tang J, Qiu S, Peng Z, Yuan Q, Xie Y, Mei W, Tang Y, Meng J, Hu G, Tao L.
    Nephrology (Carlton); 2018 Jun 27; 23(6):573-584. PubMed ID: 28437591
    [Abstract] [Full Text] [Related]

  • 29. The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury.
    Anders HJ, Suarez-Alvarez B, Grigorescu M, Foresto-Neto O, Steiger S, Desai J, Marschner JA, Honarpisheh M, Shi C, Jordan J, Müller L, Burzlaff N, Bäuerle T, Mulay SR.
    Kidney Int; 2018 Mar 27; 93(3):656-669. PubMed ID: 29241624
    [Abstract] [Full Text] [Related]

  • 30. A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease.
    Huang S, Chen Z, Fan B, Chen Y, Zhou L, Jiang B, Long H, Zhong W, Li X, Li Y.
    J Neuroimmunol; 2021 May 15; 354():577543. PubMed ID: 33714750
    [Abstract] [Full Text] [Related]

  • 31. Pharmacological inhibition of the NLRP3 inflammasome as a potential target for cancer-induced bone pain.
    Chen SP, Zhou YQ, Wang XM, Sun J, Cao F, HaiSam S, Ye DW, Tian YK.
    Pharmacol Res; 2019 Sep 15; 147():104339. PubMed ID: 31276771
    [Abstract] [Full Text] [Related]

  • 32. Celastrol augments sensitivity of NLRP3 to CP-456773 by modulating HSP-90 and inducing autophagy in dextran sodium sulphate-induced colitis in rats.
    Saber S, Abd El-Kader EM, Sharaf H, El-Shamy R, El-Saeed B, Mostafa A, Ezzat D, Shata A.
    Toxicol Appl Pharmacol; 2020 Aug 01; 400():115075. PubMed ID: 32470352
    [Abstract] [Full Text] [Related]

  • 33. Evidence against a role for NLRP3-driven islet inflammation in db/db mice.
    Kammoun HL, Allen TL, Henstridge DC, Barre S, Coll RC, Lancaster GI, Cron L, Reibe S, Chan JY, Bensellam M, Laybutt DR, Butler MS, Robertson AAB, O'Neill LA, Cooper MA, Febbraio MA.
    Mol Metab; 2018 Apr 01; 10():66-73. PubMed ID: 29478918
    [Abstract] [Full Text] [Related]

  • 34. MCC950 blocks enhanced interleukin-1β production in patients with NLRP3 low penetrance variants.
    Schuh E, Groß CJ, Wagner D, Schlüter M, Groß O, Kümpfel T.
    Clin Immunol; 2019 Jun 01; 203():45-52. PubMed ID: 30974290
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The critical role of the hippocampal NLRP3 inflammasome in social isolation-induced cognitive impairment in male mice.
    Niu L, Luo SS, Xu Y, Wang Z, Luo D, Yang H, Li W, He J, Zhong XL, Liu ZH, Zeng JY, Cao WY, Wan W.
    Neurobiol Learn Mem; 2020 Nov 01; 175():107301. PubMed ID: 32882398
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Activation of the NLRP3 Inflammasome Is Associated with Valosin-Containing Protein Myopathy.
    Nalbandian A, Khan AA, Srivastava R, Llewellyn KJ, Tan B, Shukr N, Fazli Y, Kimonis VE, BenMohamed L.
    Inflammation; 2017 Feb 01; 40(1):21-41. PubMed ID: 27730320
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.